Cationic liposomes

Research output: PatentPatent – Annual report year: 2019Research

Documents

View graph of relations

Disclosed herein are cationic liposomes suitable for specific delivery of immunomodulating agents to monocytes and dendritic cells. The cationic liposomes comprise phospholipids, cholesterol, cationic lipids, PEG and at least one active ingredient and have a zeta potential in the range of 13-25 mV. Further disclosed are uses of such cationic liposomes in various pharmaceutical applications.
Original languageEnglish
IPCA61K31/522; A61K39/39; A61K47/02; A61K47/69; A61K9/127; A61P35/00
Patent numberWO2019012107
Filing date17/01/2019
CountryInternational Bureau of the World Intellectual Property Organization (WIPO)
Priority date13/07/2017
Priority numberEP20170181122
Publication statusPublished - 2019

Download statistics

No data available

ID: 169759982